AlphaValue Corporate Services
This research has been commissioned and paid for by the company and does therefore not constitute an inducement caught by the prohibition under MiFID II

Crossject

CR
Bloomberg   ALCJ FP
Supergenerics  /  France  Web Site   |   Investors Relation
Life is a long wait…
Staff matters

At year-end 2025, Crossject employed 110 people, compared to 108 in FY24, 119 in FY23, 102 in FY22, 99 in 2021, 97 in 2020, 79 in 2019, 72 in 2018, 59 in 2017, 39 in FY16, and 23 in FY15. We anticipate an increase in this number, although all NTEs under development are expected to be marketed through partnerships, which does not necessitate a significant workforce. This situation could change if the group alters its marketing strategy, but we do not foresee Crossject marketing its products independently in the near future.

Summary
  • Summary
  • Geo. Liabilities
  • Inputs
Plans
  • Funded Oblig.
  • Plan Assets
  • Unfund. Obligations
Impacts
  • B/S Impact
  • P&L Impact
  • Corridors
Target
Upside 345%
Price (€) 1.25
Market Cap (€M) 80.6
Export all
Changes to Forecasts : 12/10/2026.